vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and WATTS WATER TECHNOLOGIES INC (WTS). Click either name above to swap in a different company.

WATTS WATER TECHNOLOGIES INC is the larger business by last-quarter revenue ($625.1M vs $397.6M, roughly 1.6× Guardian Pharmacy Services, Inc.). WATTS WATER TECHNOLOGIES INC runs the higher net margin — 13.4% vs 5.3%, a 8.1% gap on every dollar of revenue.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

AERCO International, Inc. is a manufacturer and supplier of commercial condensing boilers, high efficiency water heating equipment and energy recovery systems in the HVAC/plumbing industry across a variety of markets including education, lodging, government, office buildings, healthcare, industrial and multifamily housing. In 1949, AERCO introduced the industry's first semi-instantaneous, tankless steam-to-water water heater. In 1988, AERCO introduced the first condensing and fully modulating...

GRDN vs WTS — Head-to-Head

Bigger by revenue
WTS
WTS
1.6× larger
WTS
$625.1M
$397.6M
GRDN
Higher net margin
WTS
WTS
8.1% more per $
WTS
13.4%
5.3%
GRDN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRDN
GRDN
WTS
WTS
Revenue
$397.6M
$625.1M
Net Profit
$20.9M
$83.7M
Gross Margin
21.5%
49.5%
Operating Margin
7.7%
18.2%
Net Margin
5.3%
13.4%
Revenue YoY
15.7%
Net Profit YoY
24.0%
EPS (diluted)
$2.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
WTS
WTS
Q4 25
$397.6M
$625.1M
Q3 25
$377.4M
$611.7M
Q2 25
$344.3M
$643.7M
Q1 25
$329.3M
$558.0M
Q4 24
$540.4M
Q3 24
$314.4M
$543.6M
Q2 24
$597.3M
Q1 24
$570.9M
Net Profit
GRDN
GRDN
WTS
WTS
Q4 25
$20.9M
$83.7M
Q3 25
$9.8M
$82.2M
Q2 25
$9.0M
$100.9M
Q1 25
$9.4M
$74.0M
Q4 24
$67.5M
Q3 24
$-122.0M
$69.1M
Q2 24
$82.0M
Q1 24
$72.6M
Gross Margin
GRDN
GRDN
WTS
WTS
Q4 25
21.5%
49.5%
Q3 25
19.8%
48.8%
Q2 25
19.8%
50.6%
Q1 25
19.5%
48.8%
Q4 24
46.7%
Q3 24
19.4%
47.3%
Q2 24
47.7%
Q1 24
46.9%
Operating Margin
GRDN
GRDN
WTS
WTS
Q4 25
7.7%
18.2%
Q3 25
4.3%
18.2%
Q2 25
3.7%
21.0%
Q1 25
3.9%
15.7%
Q4 24
16.5%
Q3 24
-33.3%
17.1%
Q2 24
18.7%
Q1 24
16.9%
Net Margin
GRDN
GRDN
WTS
WTS
Q4 25
5.3%
13.4%
Q3 25
2.6%
13.4%
Q2 25
2.6%
15.7%
Q1 25
2.9%
13.3%
Q4 24
12.5%
Q3 24
-38.8%
12.7%
Q2 24
13.7%
Q1 24
12.7%
EPS (diluted)
GRDN
GRDN
WTS
WTS
Q4 25
$2.50
Q3 25
$2.45
Q2 25
$3.01
Q1 25
$2.21
Q4 24
$2.02
Q3 24
$2.06
Q2 24
$2.44
Q1 24
$2.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
WTS
WTS
Cash + ST InvestmentsLiquidity on hand
$65.6M
$405.5M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$217.9M
$2.0B
Total Assets
$412.7M
$2.9B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
WTS
WTS
Q4 25
$65.6M
$405.5M
Q3 25
$36.5M
$457.7M
Q2 25
$18.8M
$369.3M
Q1 25
$14.0M
$336.8M
Q4 24
$386.9M
Q3 24
$37.2M
$303.9M
Q2 24
$279.4M
Q1 24
$237.1M
Total Debt
GRDN
GRDN
WTS
WTS
Q4 25
$0
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$34.3M
Q2 24
Q1 24
Stockholders' Equity
GRDN
GRDN
WTS
WTS
Q4 25
$217.9M
$2.0B
Q3 25
$195.5M
$2.0B
Q2 25
$179.7M
$1.9B
Q1 25
$163.2M
$1.8B
Q4 24
$1.7B
Q3 24
$133.9M
$1.7B
Q2 24
$1.6B
Q1 24
$1.6B
Total Assets
GRDN
GRDN
WTS
WTS
Q4 25
$412.7M
$2.9B
Q3 25
$390.0M
$2.7B
Q2 25
$356.3M
$2.6B
Q1 25
$334.0M
$2.5B
Q4 24
$2.4B
Q3 24
$348.0M
$2.4B
Q2 24
$2.4B
Q1 24
$2.3B
Debt / Equity
GRDN
GRDN
WTS
WTS
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.26×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
WTS
WTS
Operating Cash FlowLast quarter
$34.6M
$154.7M
Free Cash FlowOCF − Capex
$140.3M
FCF MarginFCF / Revenue
22.4%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
1.65×
1.85×
TTM Free Cash FlowTrailing 4 quarters
$356.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
WTS
WTS
Q4 25
$34.6M
$154.7M
Q3 25
$28.2M
$122.4M
Q2 25
$19.9M
$69.7M
Q1 25
$17.6M
$55.2M
Q4 24
$139.5M
Q3 24
$90.7M
Q2 24
$85.3M
Q1 24
$45.6M
Free Cash Flow
GRDN
GRDN
WTS
WTS
Q4 25
$140.3M
Q3 25
$24.2M
$110.9M
Q2 25
$59.5M
Q1 25
$45.6M
Q4 24
$127.5M
Q3 24
$84.3M
Q2 24
$78.5M
Q1 24
$35.5M
FCF Margin
GRDN
GRDN
WTS
WTS
Q4 25
22.4%
Q3 25
6.4%
18.1%
Q2 25
9.2%
Q1 25
8.2%
Q4 24
23.6%
Q3 24
15.5%
Q2 24
13.1%
Q1 24
6.2%
Capex Intensity
GRDN
GRDN
WTS
WTS
Q4 25
2.3%
Q3 25
1.1%
1.9%
Q2 25
1.6%
Q1 25
1.7%
Q4 24
2.2%
Q3 24
1.2%
Q2 24
1.1%
Q1 24
1.8%
Cash Conversion
GRDN
GRDN
WTS
WTS
Q4 25
1.65×
1.85×
Q3 25
2.87×
1.49×
Q2 25
2.21×
0.69×
Q1 25
1.86×
0.75×
Q4 24
2.07×
Q3 24
1.31×
Q2 24
1.04×
Q1 24
0.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons